Soni Medicare Limited has scheduled its 38th Annual General Meeting for September 29, 2026. The company also proposed changes to director designations and sought shareholder approval for increased loan limits.

The Board of Directors approved the draft notice for the AGM during a meeting held on September 4, 2026, at its registered office in Jaipur. The register of members will remain closed from September 23 to September 29, 2026. Mahendra Khandelwal & Company was appointed as the scrutinizer for remote e-voting.

Governance and Director Changes

The Board proposed changing the designation of Mr. Namit Soni to Director and Mr. Lavi Kumar Mutha to Independent Director. Both appointments require final approval from the members at the upcoming AGM.

Financial Limits Approval

Shareholders must approve an increase in limits under Section 186 of the Companies Act, 2013, up to ₹100 crore. Similarly, limits under Section 185 were approved for increase up to ₹100 crore, also pending member consent.

AGM Logistics

• Date: September 29, 2026
• Time: 3:00 pm
• Venue: 38, Kanota Bagh, Jawahar Lal Nehru Marg, Jaipur
• E-voting cut-off: September 22, 2026

Shareholder Communication

In compliance with Regulation 36(1)(b) of the SEBI Listing Regulations, 2015, the company issued a letter dated September 7, 2026, to shareholders who have not registered email addresses. The communication provides web links to access the Annual Report for FY26 and the AGM notice on the company’s website.

The notice also reminds physical shareholders to update their KYC details, including PAN, bank account details, and nomination choices, as mandated by SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 7, 2024. Failure to update these details may restrict dividend payments to electronic modes only.

Soni Medicare Ltd reported a net loss of ₹253.23 lakh for the financial year ended March 31, 2026, on a total revenue of ₹2624.54 lakh. The company recorded a loss of ₹19.06 lakh for the quarter ended March 31, 2026, on revenue of ₹658.20 lakh. The audited standalone financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on May 30, 2026.

Financial Performance

The company's financial performance for the year and quarter reflects a decline in profitability compared to the previous year. For the year ended March 31, 2026, the total expenses stood at ₹2888.64 lakh, resulting in an Earnings Before Tax (EBT) of -₹264.10 lakh. In the corresponding quarter ended March 31, 2025, the company had reported a profit after tax of ₹21.60 lakh on revenue of ₹751.55 lakh.

Regulatory Compliance

The intimation regarding the submission of the newspaper publication of the audited financial results was submitted to BSE Limited on June 2, 2026. The filing confirms the publication of the results in the June 1, 2026 editions of The Financial Express (English) and Business Remedies (Hindi). The disclosure was signed by Hari Krishan Tiwari, Company Secretary & Compliance Officer.